Scientists form new Seattle biotech, backed by $12M. Fate Therapeutics
| November 30, 2007 |  View for printing |
A group of scientists who specialize in stem cell biology have formed a new biotech company backed by $12 million in original venture capital.
Fate Therapeutics will be based in Seattle and consists of leading scientists including Randall Moon of the University of Washington, who's director of the Institute for Stem Cell and Regenerative Medicine. Other scientists come from Stanford University, Harvard University and Scripps Research Institute.
Full Story: http://www.bizjournals.com/seattle/s ... na=from_rss
No reader comments so far. Be the first to comment by clicking the button below.
Reprinted under the Fair Use doctrine of international copyright law. Full copyright retained by the original publication. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.
